Eli Lilly and Company (NYSE:LLY) is one of the 10 Best Non-Tech Stocks to Buy and Hold For 3 Years. On June 22, Eli Lilly and Company (NYSE:LLY) announced new results for its once-weekly insulin, ...

Analyst Robert Ford likes the company’s strategic progress in advertising and fulfillment. He noted […] Eli Lilly and Company ...

AbbVie ABBV has successfully navigated the loss of exclusivity (LOE) for its flagship drug, Humira, by launching two newer ...

The market reaction to Trump's comments was muted. Shares of top US drugmakers Pfizer PFE.N, Merck MRK.N, Eli Lilly LLY.N, ...

Shares of US clinical-stage biotech Apogee Therapeutics closed down 17.3% at $39.24 yesterday, despite announcing positive 16 ...

Shares of WW International Inc. were climbing in Tuesday trading after the company known as WeightWatchers emerged from bankruptcy and announced a new program to support women as they go through ...

Investors in Eli Lilly (Symbol: LLY) saw new options become available today, for the August 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the LLY options ...

As we enter a new earnings season, there are several reasons for optimism about the economy. However, potential headwinds ...

Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Eli Lilly (Symbol: LLY), where a total of 18,927 contracts have traded so far, representing ...

On June 27, UBS kept its Buy rating and $1,050 price target on Eli Lilly & Company (NYSE:LLY), pointing to the pharmaceutical company’s dominant position in the market for treating obesity.

President Donald Trump on Tuesday reiterated his plans to impose tariffs on pharmaceutical goods, threatening to charge as ...